Synmosa Biopharma financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
NT$436.23M NT$512.41M NT$566.00M NT$757.27M NT$774.15M NT$858.01M NT$824.71M NT$927.81M NT$1.07B NT$1.25B NT$1.48B NT$1.78B NT$1.87B NT$1.86B NT$2.36B NT$2.68B NT$3.04B NT$3.23B NT$4.39B NT$5.14B NT$0.00M
GM % Gross Margin %
55.04% 57.47% 53.15% 46.97% 45.23% 46.46% 45.06% 47.93% 48.61% 48.75% 46.76% 46.13% 43.68% 38.60% 40.13% 33.42% 37.29% 39.73% 41.64% 41.24% 0.00%
OM Operating Margin
5.49% 7.53% 2.95% 4.10% -1.82% 2.66% -1.46% -3.37% 1.00% 3.26% -3.49% 0.94% -2.28% -6.23% -2.59% -3.98% 4.92% 5.77% 10.50% 12.00% 0.00%
EPS Earnings Per Share
NT$0.05 NT$-0.09 NT$0.24 NT$0.39 NT$0.11 NT$1.22 NT$1.82 NT$2.24 NT$1.61 NT$0.00
Div. Dividends
NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.55 NT$0.00 NT$0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 24.55% 0 0
Sha. Shares
0m 0m 113.12m 118.13m 135.13m 170.9m 181.54m 173.23m 173.94m 192.8m 209.9m 209.63m 241.72m 240.82m 233.17m 249.08m 268.31m 265.22m 297.28m 0m 382.04m
OCF Operating Cash Flow
NT$68.06M NT$46.66M NT$76.75M NT$-40.16M NT$-13.03M NT$22.56M NT$-29.95M NT$-60.39M NT$219.96M NT$30.25M NT$-11.22M NT$23.60M NT$236.48M NT$-5.19M NT$16.00M NT$-44.88M NT$254.40M NT$444.29M NT$630.25M NT$511.93M NT$0.00M
FCF Free Cash Flow
NT$10.19M NT$-308.81M NT$62.28M NT$-50.95M NT$-48.01M NT$-51.87M NT$-68.86M NT$-100.38M NT$138.09M NT$-296.66M NT$-1131.27M NT$-345.66M NT$-182.38M NT$-152.12M NT$-298.43M NT$-228.25M NT$100.00M NT$351.23M NT$500.95M NT$304.89M NT$0.00M
FCFS Free Cash Flow Per Share
NT$0.09 NT$-2.95 NT$0.53 NT$-0.51 NT$-0.46 NT$-0.50 NT$-0.46 NT$-0.69 NT$0.55 NT$-1.66 NT$-5.55 NT$-1.87 NT$-0.83 NT$-0.98 NT$-1.46 NT$-1.04 NT$0.27 NT$0.92 NT$1.25 NT$0.68 NT$0.00